Search results
30 packages found
Problem metabolizing ethanol with ADH (Alcohol dehydrogenase)
Problem metabolizing NSAIDs
Increased risk of gluten intolerance and celiac disease in europeans
Determines lower heart attack risk than average - 10-20% of people
Determines if affected by sickle cell anemia
You are at an increased risk for developing Parkinson's Disease
You have a lower risk for developing Parkinson's Disease
You have at least 4 of the 5 genotypes which increase, by approximately 50%, the risk of prostate cancer patients dying of the disease. This does not increase your risk of getting prostate cancer, however.
You have a 6.5x increased risk for breast cancer
The 3.7% or so of all individuals who are both rs965513(A;A) and rs944289(T;T) are reported to be at ~5.7x increased risk for thyroid cancer compared to noncarriers
You have a 1.7x increased risk for panic disorder
Your CYP1A2 fast metabolizer status means that you are less stimulated by caffeine.
Determine if you have two copies of the ApoE-ε4 allele
- genome
- genoset
- genes
- dna
- gs216
- genoset-216
- ApoE
- ApoE-ε4 allele
- increased risk
- Alzheimers
- Alzheimer's disease
- Cardiovascular
- Cardiovascular disease
- Hepatitis C
Of the 'poor metabolizer' phenotype for CYP2C19.
You are a CYP2C9 poor metabolizer.
Most likely CYP2C19 normal, i.e. CYP2C19*1, and therefore of the 'rapid metabolizer' phenotype.
Determines if a genome has an increased risk of Alzheimer's disease. (GS293)
Determines if a genome is 80% likely to be unable to taste bitter. (GS116)
A BioJS component for human genetic variation viewer(protein variants).
Determines if a genome has an increased risk of basal cell carcinoma as per gs126.